Encelimab (Anti-LAG3 / CD223)
Encelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody targeting the inhibitory receptor lymphocyte activation gene 3 protein (LAG3). It has potential immune checkpoint inhibitory and antineoplastic, antitumor activity. MW :144.58 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2993 |
| Sku # | A2993-1mg*25 |
| Pricing | 1mg*25, $5070.00 |